Document is current
Any future updates will be listed below
-
Authors
Liauw, Jessica https://orcid.org/0000-0002-1573-5574
Groom, Katie
Ganzevoort, Wessel
Gluud, Christian
McKinlay, Christopher J. D.
Sharp, Andrew
Mackay, Laura
Kariya, Chirag
Lim, Ken
von Dadelszen, Peter
Limpens, Jacqueline
Jakobsen, Janus C.
,
Audibert, Francois
Alfirevic, Zarko
Baker, Philip
Bujold, Emmanuel
Chung, Youkee
Cornforth, Christine
Ganzevoort, Wessel
Gordijn, Sanne J.
Groom, Katie
Gluud, Christian
Jakobsen, Janus C.
Johnstone, Edward D.
Kariya, Chirag
Kenny, Louise
Lee, Tang
Li, Larry
Liauw, Jessica
Lim, Ken
Magee, Laura
Mackay, Laura
McCowan, Lesley
McKinlay, Chris
Mol, Ben W.
Onland, Wes
Papageorghiou, Aris
Pels, Anouk
Sharp, Andrew
von Dadelszen, Peter
-
Funding
Funding for this research was provided by:
Health Research Council of New Zealand (13/242)
- License Information
-
More Information
Article History
Received: 1 March 2021
Accepted: 28 October 2021
First Online: 3 December 2021
Declarations
:
: Ethics approval details for individual STRIDER trials:New Zealand/Australia: New Zealand Health and Disability Ethics Committee (CEN/12/06/028/AM05), Royal Brisbane & Women’s Hospital Human Research Ethics Committee (HREC/14/ORBW/178), and King Edward Memorial Hospital Ethics Committee (2014071EW).Canada: University of British Columbia/Children’s and Women’s Health Centre of BC Research Ethics Board (H15–00899).The Netherlands: MET AMC (NL41894.018.14).The UK: 14.NE.0011.
: Not applicable.
: KG, WG, AS, and KL led STRIDER trials in New Zealand/Australia, the Netherlands, UK, and Canada, respectively. All authors except J. Limpens are members of the STRIDER Consortium. BWM (a member of the STRIDER consortium) is supported by a NHMRC Investigator grant (GNT1176437). BWM reports consultancy for Guerbet, has been a member of the ObsEva advisory board and hold Stock options for ObsEva. BWM has received research funding from Guerbet and Merck.
